Randomized trial of pharmacist interventions to improve depression care and outcomes in primary care

American Journal of Health-System Pharmacy

Volumn 61, Issue 4, 2004, Pages 364-372

  Capoccia, Kam L ^a,f   Boudreau, Denise M ^b   Blough, David K ^c   Ellsworth, Allan J ^c   Clark, Dave R ^d   Stevens, Nancy G ^e   Katon, Wayne J ^c   Sullivan, Sean D ^c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b CENTER FOR HEALTH STUDIES   (United States)

^c UW ^*  (United States)

^d KAISER PERMANENTE   (United States)

^e UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

Antidepressants; Compliance; Depression; Dosage; Interventions; Patient information; Patients; Pharmacists; Primary care; Quality of life; Toxicity

Indexed keywords

ANTIDEPRESSANT AGENT;

ADULT; ARTICLE; CLINICAL PHARMACY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DOSE RESPONSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; OUTCOMES RESEARCH; PATIENT COMPLIANCE; PATIENT EDUCATION; PATIENT MONITORING; PATIENT SATISFACTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RELAPSE; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; TELEPHONE; CHI SQUARE DISTRIBUTION; COMPARATIVE STUDY; ECONOMICS; FOLLOW UP; METHODOLOGY; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; NONPARAMETRIC TEST; PHARMACIST; PRIMARY HEALTH CARE; PSYCHOLOGICAL ASPECT; STATISTICS; TREATMENT OUTCOME;

ADULT; CHI-SQUARE DISTRIBUTION; DEPRESSIVE DISORDER, MAJOR; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PATIENT COMPLIANCE; PHARMACISTS; PRIMARY HEALTH CARE; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 1642566569     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/61.4.364     Document Type: Article

References (32)

1. Narrow WE, Regier DA, Rae DS et al. Use of services by persons with mental and addictive disorders. Findings from the National Institute of Mental Health Epidemiologic Catchment Program. Arch Gen Psychiatry. 1993; 50:95-107.
2. Wells KB, Schoenbaum M, Unutzer J et al. Quality of care for primary care patients with depression in managed care. Arch Fam Med. 1999; 8:529-36.
3. Katon W, Von Korff M, Lin E et al. Adequacy and duration of antidepressant treatment in primary care. Med Care. 1992; 30:67-76.
4. Wells KB, Sherbourne C, Shoenbaum M et al. Impact of disseminating quality improvement programs for depression in managed primary care: a randomized controlled trial. JAMA. 2000; 283:212-20. [Erratum, JAMA. 2000; 283:3204.]
5. Wells KB, Sherbourne C, Shoenbaum M et al. Impact of disseminating quality improvement programs for depression in managed primary care: a randomized controlled trial. JAMA. 2000; 283:212-20. [Erratum, JAMA. 2000; 283:3204.]
6. Katon W, Robinson P, Von Korff M et al. A multifaceted intervention to improve treatment of depression in primary care. Arch Gen Psychiatry. 1996; 53:924-32.
7. Schulberg HC, Block MR, Madonia MJ et al. Treating major depression in primary care practice. Eight-month clinical outcomes. Arch Gen Psychiatry. 1996; 53:913-9.
8. Mehos BM, Saseen JJ, MacLaughlin EJ. Effect of pharmacist intervention and initiation of home blood pressure monitoring in patients with uncontrolled hypertension. Pharmacotherapy. 2000; 20:1384-9.
9. Tsuyuki RT, Johnson JA, Teo KK et al. A randomized trial of the effect of community pharmacist intervention on cholesterol risk management: the Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP). Arch Intern Med. 2002; 162:1149-55.
10. Chiquette E, Amato MG, Bussey HI. Comparison of an anticoagulation clinic with usual medical care: anticoagulation control, patient outcomes, and health care costs. Arch Intern Med. 1998; 158:1641-7.
11. Knoell DL, Pierson JF, Marsh CB et al. Measurement of outcomes in adults receiving pharmaceutical care in a comprehensive asthma outpatient clinic. Pharmacotherapy. 1998; 18:1365-74.
12. Cording MA, Engelbrecht-Zadvorny EB, Pettit BJ et al. Development of a pharmacist-managed lipid clinic. Ann Pharmacother. 2002; 36:892-904.
13. Coast-Senior EA, Kroner BA, Kelley CL et al. Management of patients with type 2 diabetes by pharmacists in primary care clinics. Ann Pharmacother. 1998; 32:636-41.
14. Spitzer RL, Williams JB, Kroenke K et al. Utility of a new procedure for diagnosing mental disorders in primary care. The PRIME-MD 1000 study. JAMA. 1994; 272:1749-56.
15. Saunders JB, Aasland OG, Babor TF et al. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption-II. Addiction. 1993; 88:791-804.
16. Boudreau DM, Capoccia KL, Sullivan SD et al. Collaborative care model to improve outcomes in major depression. Ann Pharmacother. 2002; 36:585-91.
17. Derogatis LR, Rickels K, Uhlenhuth EH et al. The Hopkins Symptom Checklist: a measure of primary symptom dimension. In: Pichot P, ed. Pyschological measurements in psychopharmacology: problems in pharmacopsychiatry. Basil, Switzerland: Kargerman; 1974:79-110.
18. American Psychiatric Association. DSM-IV-TR: diagnostic and statistical manual of mental disorders, text revision. Washington, DC: American Psychiatric Press; 2000.
19. Ware JE, Kosinski M, Keller SD. SF-12: how to score the SF-12 physical and mental health summary scales. 2nd ed. Boston: New England Medical Center; 1995.
20. Little RJ, Rubin DB. Statistical analysis with missing data. New York: Wiley; 1987:3-20.
21. Katon W, Von Korff M, Lin E et al. Collaborative management to achieve treatment guidelines. Impact on depression in primary care. JAMA. 1995; 273:1026-31.
22. Finley PR, Rens HR, Pont JT et al. Impact of a collaborative pharmacy practice model on the treatment of depression in primary care. Am J Health-Syst Pharm. 2002; 59:1518-26.
23. Simon GE, Katon W, Rutter C et al. Impact of improved depression treatment in primary care on daily functioning and disability. Psychol Med. 1998; 28:693-701.
24. Lin EH, Katon WJ, Simon GE et al. Achieving guidelines for the treatment of depression in primary care: is physician education enough? Med Care. 1997; 35:831-42.
25. Agency for Health Care Policy and Research. Clinical practice guideline number 5: depression in primary care. Vol. 2. Treatment of major depression. Rockville, MD: U.S. Department of Health and Human Services, 1993; AHCPR publication no. 93-0551.
26. Schulberg HC, Katon W, Simon GE et al. Treating major depression in primary care practice: an update of the Agency for Health Care Policy and Research practice guidelines. Arch Gen Psychiatry. 1998; 55:1121-7.
27. Cotterchio M, Kreiger N, Darlington G et al. Comparison of self-reported and physician-reported antidepressant medication use. Ann Epidemiol. 1999; 9:283-9.
28. Kwon A, Bungay KM, Pei Y et al. Antidepressant use: concordance between self-report and claims records. Med Care. 2003; 41:368-74.
29. Boudreau DM, Daling JR, Malone KE et al. A validation study of patient interview data and pharmacy records for antihypertensive, statin, and antidepressant medication use among older women. Am J Epidemiol. In press.
30. Schumock GT, Meek PD, Ploetz PA et al. Economic evaluations of clinical pharmacy services-1988-1995. Pharmacotherapy. 1996; 16:1188-208.
31. McMullin ST, Hennenfent JA, Ritchie DJ et al. A prospective, randomized trial to assess the cost impact of pharmacist-initiated interventions. Arch Intern Med. 1999; 159:2306-9.
32. Leape LL, Cullen DJ, Clapp MD et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA. 1999; 282:267-70.